Dr. Helen Wheeler, MD
Claim this profileRoyal North Shore Hospital
Studies Mesial Temporal Sclerosis
Studies Brain Tumor
2 reported clinical trials
9 drugs studied
Clinical Trials Helen Wheeler, MD is currently running
Multiple Therapies
for Glioblastoma
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Recruiting1 award Phase 2 & 310 criteria
ONC201
for Brain Tumor
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse glioma to assess whether treatment with ONC201 following frontline radiotherapy will extend overall survival and progression-free survival in this population. Eligible participants will have histologically diagnosed H3 K27M-mutant diffuse glioma and have completed standard frontline radiotherapy.
Recruiting1 award Phase 3
More about Helen Wheeler, MD
Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Helen Wheeler, MD has experience with
- ONC201
- Lomustine
- Paxalisib
- Radiation
- Regorafenib
- Temozolomide
Breakdown of trials Helen Wheeler, MD has run
Mesial Temporal Sclerosis
Brain Tumor
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Helen Wheeler, MD specialize in?
Helen Wheeler, MD focuses on Mesial Temporal Sclerosis and Brain Tumor. In particular, much of their work with Mesial Temporal Sclerosis has involved H3 K27M positive patients, or patients who are undergoing treatment.
Is Helen Wheeler, MD currently recruiting for clinical trials?
Yes, Helen Wheeler, MD is currently recruiting for 2 clinical trials in Sydney New South Wales. If you're interested in participating, you should apply.
Are there any treatments that Helen Wheeler, MD has studied deeply?
Yes, Helen Wheeler, MD has studied treatments such as ONC201, Lomustine, Paxalisib.
What is the best way to schedule an appointment with Helen Wheeler, MD?
Apply for one of the trials that Helen Wheeler, MD is conducting.
What is the office address of Helen Wheeler, MD?
The office of Helen Wheeler, MD is located at: Royal North Shore Hospital, Sydney, New South Wales 2065 Australia. This is the address for their practice at the Royal North Shore Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.